Six Frequently Asked Questions About KYBELLA

Want to learn more about KYBELLA and how it works? Here are the key questions answered, with a deep dive into this revolutionary non-surgical treatment for submental fat, commonly known as a double chin. KYBELLA is the first and only FDA-approved treatment specifically designed to improve the appearance of the double chin. Whether you’ve been thinking about ways to contour your jawline or eliminate stubborn chin fat, KYBELLA might be the solution you’ve been looking for.

What is KYBELLA?

KYBELLA is a prescription injectable containing synthetic deoxycholic acid, a naturally occurring molecule in the body that aids in breaking down dietary fat. When injected into the fat beneath the chin, it works to destroy fat cells, reducing fullness and helping to contour the chin area. Once these fat cells are destroyed, they are permanently eliminated, and you won’t need further treatments after reaching your desired aesthetic. However, a healthy lifestyle is key to maintaining these results.

How does KYBELLA work?

KYBELLA targets and destroys fat cells using deoxycholic acid. When injected into the chin area, it breaks down fat cells, which are then naturally eliminated by the body over time. This treatment is personalized based on the amount of submental fat and your aesthetic goals. Most clients notice results after two to four treatments, though some may require up to six treatments spaced at least a month apart. Once the fat is gone, it doesn’t come back.

What is a KYBELLA treatment like?

The treatment process is straightforward and quick. Here’s what to expect:

  • Consultation: Before treatment, you'll meet with a SkinSpirit expert to evaluate your needs and create a customized treatment plan.
  • Injection: KYBELLA is administered through a series of small injections under your chin. Each session typically lasts 15 to 20 minutes.
  • Recovery: Most clients can return to their normal activities right away, though some may experience mild swelling, bruising, or discomfort at the injection site for a few days.

What results should I expect?

Once you’ve completed your KYBELLA treatments, the results are permanent for the treated fat cells. Clients report feeling more confident, younger, and happier with their appearance, often feeling less self-conscious about their double chin. Around 79% of clients in clinical studies reported satisfaction with their results.

Is there downtime or any side effects?

Most clients experience minimal downtime, especially after their first treatment. However, some swelling, bruising, or redness may occur. Common side effects include:

  • Swelling
  • Bruising
  • Numbness
  • Redness
  • Firmness at the treatment area

These side effects generally improve with subsequent treatments. In rare cases, more serious side effects such as difficulty swallowing or nerve injury in the jaw area may occur. Be sure to discuss any concerns with your practitioner beforehand.

Why choose KYBELLA over surgery?

For those considering surgical options like liposuction, KYBELLA offers a non-invasive alternative with benefits like:

  • No anesthesia or incisions
  • Minimal downtime
  • Permanent fat cell destruction

Want to see if you’re a good candidate for KYBELLA?

We recommend coming in for a complimentary consultation with one of our SkinSpirit experts. They’ll help determine if KYBELLA is the right treatment for you and answer any questions you may have. Schedule your consultation at one of our locations:

You May Also Be Interested In:

Disclaimer: Information and content within this blog is provided for informational purposes only.  This blog is not intended to provide medical advice, and anything read here should not be construed as such.  Reading this blog or communicating with our staff does not create a physician-patient relationship.  If you have questions about any health issue, including something you may have read here, please consult a licensed, trained physician or health professional immediately.

In the press

VogueWomen's HealthELLEstyleThe New York TimesUSA Today